Pressure BioSciences Joins Uptick Newswire’s Stock Day Podcast to Share the Achievement of Another Important Milestone in the Development of Its Proprietary Ultra Shear Technology Platform – Press Release


SOUTH EASTON, MA / ACCESSWIRE / November 20, 2018 / Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. The Company’s President and CEO, Mr. Richard T. Schumacher, joined Stock Day’s Mr. Everett Jolly to announce the achievement of yet another important milestone in the advancement of its proprietary Ultra Shear Technology (UST) platform and commercialization program.

Mr. Jolly began the interview by commenting that Mr. Schumacher must have some very exciting news to share, as he had appeared on the Stock Day Podcast just ten days earlier. Mr. Schumacher thanked Mr. Jolley for the opportunity to be back so soon and acknowledged that he did want to share some very exciting news with Mr. Jolley and his listeners: that in just 10 days since announcing the development of the first working prototype of the UST system that PBI had indeed achieved a second milestone – the development of a proprietary method for making high quality, water-soluble oils. Mr. Schumacher stated that the Company believed this achievement would open major new opportunities in multiple markets and should lead to revenue generation in 2019.

Mr. Schumacher said: ”We are a worldwide leader in using high pressure to solve problems. To date, our focus has been in developing and selling high-pressure instruments and consumables into the biotech and biopharma research area. Recently, we were told of a problem in the cannabis area and asked if our high-pressure technology might be able to solve the issue. We decided to accept the challenge.”

The discussion then turned to CBD, a non-psycho-active compound extracted from the cannabis plant that many believe has beneficial medicinal properties. CBD is extracted from the plant in an oil. Since oils are not well absorbed by the body after ingestion, the majority of CBD in CBD oil is thought to be flushed out and be not available to offer its benefits. It was therefore discussed, if CBD oil could be made water-soluble, perhaps far more CBD would be absorbed and consequently available for use by the body.

Mr. Jolly asked if this was the problem that PBI was trying to fix.

Mr. Schumacher responded: ”We know if oil drops can be broken down to a very small size, these ”nano” droplets can actually dissolve in water. Such a solution of nanosize oil droplets and water is an example of a nanoemulsion. So, we decided to combine ultra high pressure with intense shearing (or cutting) to turn oil and water into a nanoemulsion, to see if they would mix – and they did! This is the basis of our Ultra Shear Technology platform.”

Mr. Jolly commented: ”So the first milestone you reached 10 days ago was to make the first working prototype of the UST System, and now the second milestone achieved that you just announced was the method for making the nanoemulsion with the working prototype. Incredible.”

Mr. Schumacher then mentioned that if any of Mr. Jolly’s listeners were interested in seeing how UST actually worked – that is, how it make oil and water mix – they were welcomed to view a short video entitled, ”Revolution in Maximizing the Effectiveness of CBD Oil: How a World Leader in High-Pressure Technology Made CBD Oil Truly Water Soluble” by visiting the landing page of the PBIO website or by clicking this link: https://vimeo.com/301010614.

Mr. Jolly expressed his own excitement for the UST platform and the milestones achieved by the PBIO Team. He then asked Mr. Schumacher tell him and his listeners more about where PBI intended to take the UST system, and specifically, how PBI intended to monetize their proprietary platform.

Mr. Schumacher responded: ”There are multiple products in many different markets that we believe can benefit from nanoemulsions made by UST. These markets include but are certainly not limited to, food and beverages, cosmetics, pharmaceuticals, nutraceuticals, industrial lubricants, paints, and personal care products such as sunscreens. However, because of the excellent data generated to date, the clear need for water-soluble CBD oil, its current rapid and exciting growth, and the potential to generate a strong return for our shareholders, we have chosen to focus first on the CBD market. That said, we plan to keep a very keen eye on the other markets as well.”

Mr. Jolly asked if there were any patents surrounding this advanced technology. Mr. Schumacher responded that the Company had filed patents on two integral components of the UST system, the BaroIsolators™ (to keep the solution being processed
separate from the pressurizing fluid) and the BaroShear™ valve (the part that shears the oil to nano size droplets). Mr. Schumacher noted that both the BaroIsolators and the BaroShear Valve had been issued patents in
China, and that the Company believed it would be issued patents on both components in many North American, European, and Asian countries in the near future, as well.

Mr. Jolly then asked: ”What’s the plan from here going forward? Are you going to keep everything in-house or are we going to license out the technology?”

Mr. Schumacher replied: ”We are currently looking at a number of different opportunities; in that regards, we are now talking to different groups in the cannabis space. One option would be to build a number of UST instruments (following the existing sales model we have in the biotechnology space) and to sell the instruments to end users. The other would be to license the UST technology platform to one or a few larger companies. Both options are very viable – as we continue to develop and optimize the UST platform, we will concomitantly discuss these and other options with companies and other interested parties in the cannabis market.”

To close the interview, Mr. Jolly emphatically said: ”In my opinion, Pressure BioSciences, with all its patented platform technologies and achievements, is grossly undervalued. When investors finally get to the conclusion I have, that the UST technology platform that PBI has the potential to bring about a paradigm shift in the cannabis industry, I believe that this stock is going to absolutely take off.”

To hear all of Mr. Schumacher’s interview with Stock Day, please go here: https://upticknewswire.com/featured-interview-ceo-ric-schumacher-of-pressure-biosciences-inc-otcqb-pbio-10/

About Pressure BioSciences Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or ”PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, food science, soil & plant biology, forensics, and counter-bioterror applications. Additionally, PBIO is actively expanding the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired PreEMT technology from BaroFold, Inc. to allow entry into the biologics contract research services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (”UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.

For more information: https://www.pressurebiosciences.com/about-us

Forward-Looking Statements

This press release includes ”forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as ”expect,” ”estimate,” ”project,””budget,” ”forecast,” ”anticipate,” ”intend,” ”plan,” ”may,” ”will,” ”could,” ”should,” ”believes,” ”predicts,” ”potential,” ”continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors
are contained in the Company’s most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.

About Uptick Newswire and the ”Stock Day” Podcast

Founded in 2013, Uptick Newswire is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Uptick provides companies with customized solutions to their news distribution in both national and international media outlets.
Uptickis the sole producer of its ”Stock Day” Podcast, which is the number one radio show of its kind in America. The Uptick Network ”Stock Day” Podcast is an extension of Uptick Newswire, which recently launched its Video Interview Studio located in Phoenix, Arizona.

Investors Hangout is a proud sponsor of ”Stock Day,” and Uptick Newswire encourages listeners to visit the company’s message board at https://investorshangout.com/

Contact:

602-441-3474
https://upticknewswire.com/

SOURCE: Uptick Newswire

View source version on accesswire.com:
https://www.accesswire.com/528531/Pressure-BioSciences-Joins-Uptick-Newswires-Stock-Day-Podcast-to-Share-the-Achievement-of-Another-Important-Milestone-in-the-Development-of-Its-Proprietary-Ultra-Shear-Technology-Platform





Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *